October 24-28, 2024, Boston, Massachusetts, USA

American College Of Allergy, Asthma & Immunology

(ACAAI)

November 9–13, 2023, Anaheim, California, USA

American College Of Allergy, Asthma & Immunology

(ACAAI)

Poster icon

No Clinically Meaningful Impact of Remibrutinib on Immunoglobulin Levels or Infections in Chronic Spontaneous Urticaria

M. Palumbo, G. Sussman, S. Gogate, A. Fukunaga, S.F. Thomsen, A. Burciu,, P. Wang, M. Maurer
Poster icon

REMIX-1/-2: Early Symptom Improvements With Remibrutinib in Chronic Spontaneous Urticaria From Week 1

S. Saini, R. Szalewski, X. Gao, S. Altrichter, S. Haemmerle, N. Seko, M. Hide
Poster icon

Clinical Relevance of Urticaria Activity Scores From the Patient Perspective

D. Whalley, S. Sauchelli, M.M. Balp, R. Kohli, P. Orfanos
© Copyright 2025 Novartis Pharma AG